CTRI Number |
CTRI/2014/11/005190 [Registered on: 10/11/2014] Trial Registered Retrospectively |
Last Modified On: |
06/11/2014 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
A study to compare two different ways of giving fentanyl drug– continuous infusion or intermittent doses for pain relief in newborn babies |
Scientific Title of Study
|
Comparison of continuous infusion versus intermittent bolus doses of fentanyl for analgesia in neonates– An open label randomized controlled trial |
Trial Acronym |
FANCI trial |
Secondary IDs if Any
|
Secondary ID |
Identifier |
nil |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Abiramalatha T |
Designation |
Senior PG Registrar (DM Neonatology) |
Affiliation |
Christian Medical College, Vellore |
Address |
Department of Neonatology, ISSCC Building, Christian Medical College, Vellore
Vellore TAMIL NADU 632004 India |
Phone |
04163073311 |
Fax |
0416-2232035 |
Email |
abi_paeds@yahoo.com |
|
Details of Contact Person Scientific Query
|
Name |
DrKurien Anil Kuruvilla |
Designation |
Professor |
Affiliation |
Christian Medical College, Vellore |
Address |
Department of Neonatology, ISSCC Building, Christian Medical College, Vellore
Vellore TAMIL NADU 632004 India |
Phone |
04163073311 |
Fax |
0416-2232035 |
Email |
anilkk@cmcvellore.ac.in |
|
Details of Contact Person Public Query
|
Name |
Abiramalatha T |
Designation |
Senior PG Registrar (DM Neonatology) |
Affiliation |
Christian Medical College, Vellore |
Address |
Department of Neonatology, ISSCC Building, Christian Medical College, Vellore
Vellore TAMIL NADU 632004 India |
Phone |
04163073311 |
Fax |
0416-2232035 |
Email |
abi_paeds@yahoo.com |
|
Source of Monetary or Material Support
|
Department fund, Department of Neonatology, Christian Medical College, Vellore |
Institutional Review Board, Christian Medical College, Vellore |
|
Primary Sponsor
|
Name |
Institutional Review Board |
Address |
Christian Medical College
Vellore |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Abiramalatha T |
Level 3 nursery |
Department of Neonatology
ISSCC Building
Christian Medical College
Vellore Vellore TAMIL NADU |
04163073311
abi_paeds@yahoo.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Christian Medical College,Vellore |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
Analgesia and Sedation for neonates on mechanical ventilation, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Continuous infusion of fentanyl |
Continuous infusion of fentanyl 1 microgram/kg/hour for 48 hours (minimum 24 hours) |
Intervention |
Intermittent doses of fentanyl |
Intermittent doses of fentanyl 1 microgram/kg/dose once every 4 hours for 48 hours (minimum 24 hours) |
|
Inclusion Criteria
|
Age From |
0.00 Day(s) |
Age To |
28.00 Day(s) |
Gender |
Both |
Details |
Newborn babies who are likely to require mechanical ventilation for 48 hours (minimum 24 hours) |
|
ExclusionCriteria |
Details |
1.Major congenital anomalies/ chromosomal disorders 2.Hypoxic Ischemic encephalopathy (HIE) stage 2 or 3 3.Postoperative babies
4.Refusal of consent |
|
Method of Generating Random Sequence
|
Stratified block randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
To compare the exposure as concentrations of Fentanyl achieved in the serum between the two groups |
Continuous Infusion - Fentanyl serum concentrations at: 0, 2, 8, 24 hours on DAY 1. 36 and 48 hours on DAY 2.
Intermittent dosage Group - Fentanyl serum concentrations as peak and trough concentrations for dose 1 and 6–DAY 1, peak and trough for dose 12 (or last dose, whichever is later) on DAY 2 |
|
Secondary Outcome
|
Outcome |
TimePoints |
To measure the exposure as Cmax (peak concentration) and area under concentration time curve (AUC 0-24 hours or AUC 0-48 hours) in babies receiving continuous infusion of fentanyl |
Fentanyl serum concentrations at 0, 2, 8, 24 hours on DAY 1 and 36, 48 hours on DAY 2 |
To measure the exposure as Cmax (when measured) at each bolus and AUC, through the 24 hour (or 48 hour) period, using limited time points, in babies receiving intermittent bolus doses of fentanyl |
Fentanyl serum concentrations as peak and trough concentrations for dose 1 and 6 on DAY 1, peak and trough for dose 12 (or last dose, whichever is later) on DAY 2 |
To find the inter-individual variability in serum concentrations of fentanyl in the two groups, especially the effect of gestational age on fentanyl clearance |
Day 1 and 2 of fentanyl |
To compare the analgesic efficacy between continuous infusion and intermittent bolus doses of fentanyl using pain scores |
Day 1 and 2 of fentanyl |
To compare the side effects of fentanyl between the two groups |
Day 1 and 2 of fentanyl |
|
Target Sample Size
|
Total Sample Size="98" Sample Size from India="98"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
01/11/2014 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Open to Recruitment |
Publication Details
|
The trial will be published in an indexed journal |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
Background Fentanyl is commonly used for analgesia in newborn infants. The drug has a rapid clearance in adults. But hepatic metabolism is immature at birth, thus the half- life is prolonged in neonates. So, intermittent doses of fentanyl may be as good as continuous infusion in maintaining serum concentrations and hence the analgesic efficacy in neonates. Aim To compare continuous infusion and intermittent doses of fentanyl for analgesia in neonates using serum concentrations, pain scores and side-effects Methods In the present study, newborn babies who are likely to need mechanical ventilation and hence analgesia and sedation for preferably 48 hours (minimum of 24 hours) will be recruited into the study after informed written consent. The babies will be stratified into 2 categories of <32 weeks or ≥32 weeks gestational age. In both groups, babies will be administered a loading dose of fentanyl (1 microgram/kg/dose) at the time of intubation, or at the time of starting ventilator care if the baby has already been intubated in the labour room or casualty. Babies will be randomized into two groups: continuous infusion of fentanyl (Group 1) or intermittent doses once in every 4 hours (Group 2). The babies in the continuous group and intermittent group will be compared based on: 1) serum fentanyl concentrations 2) clinical efficacy 3) adverse effects. Serum concentrations of fentanyl will be estimated as follows: Group 1 - Continuous infusion - samples (0.5 ml) will be collected a. Prior to starting continuous infusion(0 hour) and at 2,8 and 24 hours from start of infusion b. At 36 and 48 hours - 2 samples on Day 2 Group 2 - Intermittent doses– a. Peak (Cmax) and trough concentrations of the 1st dose (at 0 and 4 hours) b. Peak and trough concentrations of the 6th dose (at 20 and 24 hours) on day 1 c. On Day 2 , peak and trough of the 12th dose or the last dose, whichever is later Pain assessment will be done clinically using standard neonatal pain scoring systems, viz. N-PASS to assess ongoing pain, and NIPS to assess acute pain during heel prick, intravenous cannulation or other procedures. Adverse effects of fentanyl will also be assessed in both groups 1. Decreased gastrointestinal motility will be assessed daily based on not passing meconium, and gastric retention defined by the volume of nasogastric aspirate/vomiting in 24 hours. 2. Urinary retention (loss of spontaneous urination with enlarged bladder/ need for catheterization) will be evaluated daily. 3. Incidence of hypotension (Blood pressure < 10th percentile for the gestational age and postnatal age) 4. Chest wall rigidity (clinically defined as no chest rise despite patent airway and adequate pressures with either mechanical or manual ventilation).
|